Hankyel Park

Array ( [id] => 4137666 [patent_doc_number] => 06060254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Reagent for examining agglutination of virus and kit for virus examination' [patent_app_type] => 1 [patent_app_number] => 9/011748 [patent_app_country] => US [patent_app_date] => 1998-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4499 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060254.pdf [firstpage_image] =>[orig_patent_app_number] => 011748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4166756 [patent_doc_number] => 06140043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the IFN-receptor and means for diagnosis of an HIV infection' [patent_app_type] => 1 [patent_app_number] => 9/029052 [patent_app_country] => US [patent_app_date] => 1998-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6423 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140043.pdf [firstpage_image] =>[orig_patent_app_number] => 029052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404679 [patent_doc_number] => 06232122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Inhibition of gene expression' [patent_app_type] => 1 [patent_app_number] => 8/983440 [patent_app_country] => US [patent_app_date] => 1998-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 9104 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232122.pdf [firstpage_image] =>[orig_patent_app_number] => 983440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234137 [patent_doc_number] => 06143520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Expression vectors and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/060659 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 40 [patent_no_of_words] => 4999 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143520.pdf [firstpage_image] =>[orig_patent_app_number] => 060659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4405729 [patent_doc_number] => 06238858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Transgenomic viruses' [patent_app_type] => 1 [patent_app_number] => 9/058686 [patent_app_country] => US [patent_app_date] => 1998-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13613 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238858.pdf [firstpage_image] =>[orig_patent_app_number] => 058686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320457 [patent_doc_number] => 06328976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor' [patent_app_type] => 1 [patent_app_number] => 9/055075 [patent_app_country] => US [patent_app_date] => 1998-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 16136 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/328/06328976.pdf [firstpage_image] =>[orig_patent_app_number] => 055075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408096 [patent_doc_number] => 06271354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Chimeric viral proteins' [patent_app_type] => 1 [patent_app_number] => 9/053941 [patent_app_country] => US [patent_app_date] => 1998-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14548 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271354.pdf [firstpage_image] =>[orig_patent_app_number] => 053941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4136175 [patent_doc_number] => 06121425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Metal-lipid molecules' [patent_app_type] => 1 [patent_app_number] => 9/039601 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19839 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121425.pdf [firstpage_image] =>[orig_patent_app_number] => 039601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4219138 [patent_doc_number] => 06111087 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Expression of a foamy virus envelope protein' [patent_app_type] => 1 [patent_app_number] => 9/042012 [patent_app_country] => US [patent_app_date] => 1998-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 11854 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/111/06111087.pdf [firstpage_image] =>[orig_patent_app_number] => 042012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4170726 [patent_doc_number] => 06083685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Systematic extraction, amplification and detection of retroviral sequences, and oligonucleotides for use therein' [patent_app_type] => 1 [patent_app_number] => 9/043085 [patent_app_country] => US [patent_app_date] => 1998-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7013 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083685.pdf [firstpage_image] =>[orig_patent_app_number] => 043085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4417248 [patent_doc_number] => 06224902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Vaccines against sterols' [patent_app_type] => 1 [patent_app_number] => 9/023256 [patent_app_country] => US [patent_app_date] => 1998-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 12817 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/224/06224902.pdf [firstpage_image] =>[orig_patent_app_number] => 023256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181228 [patent_doc_number] => 06150156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Bacillus thuringiensis isolates active against sucking insects' [patent_app_type] => 1 [patent_app_number] => 9/021234 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5145 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150156.pdf [firstpage_image] =>[orig_patent_app_number] => 021234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4189726 [patent_doc_number] => 06043042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Antibody for a toxin assay, and method of obtaining same' [patent_app_type] => 1 [patent_app_number] => 9/015960 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9855 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043042.pdf [firstpage_image] =>[orig_patent_app_number] => 015960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4219391 [patent_doc_number] => 06087486 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Nucleotide sequences encoding vpr receptor protein' [patent_app_type] => 1 [patent_app_number] => 9/014877 [patent_app_country] => US [patent_app_date] => 1998-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10194 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087486.pdf [firstpage_image] =>[orig_patent_app_number] => 014877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306908 [patent_doc_number] => 06252059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Detection of human immunodeficiency virus type 1' [patent_app_type] => 1 [patent_app_number] => 9/013406 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10460 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/252/06252059.pdf [firstpage_image] =>[orig_patent_app_number] => 013406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935461 [patent_doc_number] => 05989562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection' [patent_app_type] => 1 [patent_app_number] => 9/007383 [patent_app_country] => US [patent_app_date] => 1998-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 11 [patent_no_of_words] => 10818 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989562.pdf [firstpage_image] =>[orig_patent_app_number] => 007383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034516 [patent_doc_number] => 05994516 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Mutated proteins encoded by a lentivirus mutated env gene, peptide fragments and expression vectors' [patent_app_type] => 1 [patent_app_number] => 8/913953 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6227 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994516.pdf [firstpage_image] =>[orig_patent_app_number] => 913953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032636 [patent_doc_number] => 05942401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Method of determining favorable prognosis against progressing from an asymptomatic condition to AIDS in an human immunodeficiency virus (HIV) positive subject' [patent_app_type] => 1 [patent_app_number] => 8/995916 [patent_app_country] => US [patent_app_date] => 1997-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 5757 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942401.pdf [firstpage_image] =>[orig_patent_app_number] => 995916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4139919 [patent_doc_number] => 06030769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Group O HIV-1, fragments of such viruses, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/894699 [patent_app_country] => US [patent_app_date] => 1997-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 12554 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030769.pdf [firstpage_image] =>[orig_patent_app_number] => 894699 [rel_patent_id] =>[rel_patent_doc_number] =>)